Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 7:37 PM ET

Diversified Financial Services

Company Overview of Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc.

Company Overview

In July 2000, Curis, Inc. completed a merger with Creative BioMolecules, Inc.; Ontogeny, Inc.; and Reprogenesis, Inc., pursuant to which Curis was owned approximately 43% by the former stockholders of Creative, approximately 38% by the former stockholders of Ontogeny, and approximately 19% by the former stockholders of Reprogenesis. Previously, Curis, Inc. did not have any significant operations and was formed to effect a merger.

61 Moulton Street

Cambridge, MA 02138

United States

Founded in 2000



Key Executives for Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc.

Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Met Capital, LLC United States
Triangle Credit Union United States
Ralphs Federal Credit Union United States
Universal City Studios Credit Union United States
CapitalSource Servicing LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at